| lymfoproliferatieve aandoening door methotrexaat (aandoening) | | lymfoproliferatieve aandoening door methotrexaat | | Lymphoproliferative disorder caused by methotrexate | | Methotrexate-associated lymphoproliferative disorder
| | Rare immunodeficiency-associated lymphoproliferative disease with characteristics of lymphoid proliferation or lymphomas (large B-cell lymphoma, T-cell lymphoma, Hodgkin lymphoma, reactive lymphadenitis and a polymorphic post-transplant lymphoproliferative disorder) that develop in patients with different autoimmune diseases treated with methotrexate. Swelling is the predominant manifestation of the disease and regression after methotrexate withdrawal is observed in a significant proportion of patients. |
| | DHD Diagnosis thesaurus reference set |
| RIVM authorized national diagnosis thesaurus to ICD10 complex mapping reference set | | Target | D47.9 | | Term | Neoplasma met onzeker of onbekend gedrag van lymfoïd, hematopoëtisch en verwant weefsel, niet gespecificeerd |
| Target | Y43.1 | | Term | Ongewenste gevolgen bij therapeutisch gebruik van antineoplastische antimetabolieten |
|
| SNOMED CT to Orphanet simple map | 86904 |
| SNOMED CT to ICD-10 extended map | | Target | D47.9 | | Rule | TRUE | | Advice | ALWAYS D47.9 | POSSIBLE REQUIREMENT FOR MORPHOLOGY CODE | | Correlation | SNOMED CT source code to target map code correlation not specified |
| Target | Y43.1 | | Rule | TRUE | | Advice | ALWAYS Y43.1 | | Correlation | SNOMED CT source code to target map code correlation not specified |
|
|
